NCT03852459View on ClinicalTrials.gov

Controlled Study to Assess the Efficacy and Safety of S-Ibuprofen Topical Gel 5% (AP0302) in the Treatment of DOMS

PHASE2CompletedINTERVENTIONAL
Enrollment

251

Participants

Timeline

Start Date

January 12, 2018

Primary Completion Date

April 4, 2019

Study Completion Date

April 11, 2019

Conditions
Pain, Acute
Interventions
DRUG

S-Ibuprofen

Topical Gel 5%

DRUG

Vehicle

Vehicle Gel

Trial Locations (1)

84107

JBR Clinical Research, Salt Lake City

Sponsors
All Listed Sponsors
lead

Aponia Laboratories, Inc.

INDUSTRY

NCT03852459 - Controlled Study to Assess the Efficacy and Safety of S-Ibuprofen Topical Gel 5% (AP0302) in the Treatment of DOMS | Biotech Hunter | Biotech Hunter